Teva Pharmaceutical Industries, the Israeli generic drug-maker, plans to expand it’s pharmaceutical company this year through a number of acquisitions, potentially creating new pharmaceutical jobs in the process.
From 2012, the pharmaceutical giant plans to triple its annual revenue in women’s health to $1 billion. In addition, Teva also plans to expand its presence in oncology. The company has recently signed a $344 million deal with US biotech company Mersana Therapeutics, for marketing rights for Mersana’s cancer drug XMT-1107.
Are you looking for a job in the pharmaceutical industry? Click here to search our current pharmaceutical job vacancies.